5 results match your criteria: "Stoke-on-Trent and Royal Stoke Hospital[Affiliation]"
Circ Cardiovasc Interv
October 2018
Department of Cardiology, Sussex Cardiac Centre, Brighton and Sussex University Hospitals, United Kingdom (J.C., D.H.-S.).
Circ Cardiovasc Interv
September 2017
From the Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom (T.K., R.A., N.O.-G.); Department of Cardiology, Sussex Cardiac Centre, Brighton and Sussex University Hospitals, United Kingdom (J.C.); Department of Cardiology, University College Hospital, London, United Kingdom (A.S.); Department of Cardiology, Queen Elizabeth Hospital, Birmingham, United Kingdom (P.L.); Department of Cardiology, The James Cook University Hospital, Middlesbrough, United Kingdom (M.d.B.); Department of Cardiology, Bristol Royal Infirmary, United Kingdom (T.W.J.); Department of Biostatistics, Biosensors SA, Morges, Switzerland (S.C.); Department of Cardiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom (A.Z.); Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom (A.Z.); Keele Cardiovascular Research Group, Institute of Applied Clinical Sciences, University of Keele, Staffordshire, United Kingdom (M.A.M.); and Department of Cardiology, Stoke-on-Trent and Royal Stoke Hospital, University Hospital of North Midlands, Stoke-on-Trent, United Kingdom (M.A.M.).
Circ Cardiovasc Interv
May 2017
From the Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom (T.K., R.A., N.O.-G.); Department of Cardiology, Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton, United Kingdom (J.C., D.H.-S.); Department of Cardiology, University College Hospital, London, United Kingdom (A.S.); Department of Cardiology, Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom (P.L.); Department of Cardiology, The James Cook University Hospital, Middlesbrough, United Kingdom (M.d.); Department of Cardiology, Royal Victoria Hospital, Belfast, United Kingdom (S.W., C.H.); Department of Cardiology, St Bartholomew's Hospital, London (E.S.); Department of Cardiology, Edinburgh Royal Infirmary, United Kingdom (J. Spratt); Department of Cardiology, Bristol Royal Infirmary, United Kingdom (J. Strange); and Keele Cardiovascular Research Group, Institute of Applied Clinical Sciences, University of Keele, Stoke-on-Trent and Royal Stoke Hospital, UHNM, Stoke-on-Trent, United Kingdom (M.A.M.).
Medicine (Baltimore)
October 2016
Health eResearch Centre, Farr Institute for Health Informatics Research NIHR Greater Manchester Primary Care Patient Safety Translational Research Centre, Institute of Population Health NIHR School for Primary Care Research, University of Manchester, Manchester Research Institute for Primary Care & Health Sciences, Arthritis Research UK Primary Care Centre, Keele University, Keele, Staffordshire, United Kingdom Cardiovascular Department, Hôpital de La Tour, Geneva, Switzerland Keele Cardiovascular Research Group, Keele University Stoke-on-Trent and Royal Stoke Hospital, University Hospital North Midlands, Stoke-on-Trent, United Kingdom.
Multimorbidity is common among older people and presents a major challenge to health systems worldwide. Metrics of multimorbidity are, however, crude: focusing on measuring comorbid conditions at single time-points rather than reflecting the longitudinal and additive nature of chronic conditions. In this paper, we explore longitudinal comorbidity metrics and their value in predicting mortality.
View Article and Find Full Text PDFCirc Cardiovasc Interv
August 2016
From the Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom (T.K., N.O.-G., R.A.); Keele Cardiovascular Research Group, Institute of Science and Technology in Medicine and Primary Care and Health Sciences, University of Keele, Stoke-on-Trent and Royal Stoke Hospital, UHNM, Stoke-on-Trent, United Kingdom (C.S.K., M.A.M.); Farr Institute, University of Manchester, United Kingdom (E.K., M.A.M.); Department of Cardiology, Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom (P.L.); and Department of Cardiology, The James Cook University Hospital, Middlesborough, United Kingdom (M.d.B.).
Background: As coronary perforation (CP) is a rare but serious complication of percutaneous coronary intervention (PCI) the current evidence base is limited to small series. Using a national PCI database, the incidence, predictors, and outcomes of CP as a complication of PCI were defined.
Methods And Results: Data were prospectively collected and retrospectively analyzed from the British Cardiovascular Intervention Society data set on all PCI procedures performed in England and Wales between 2006 and 2013.